Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol (BRCX014) Combined With Standard-Of-Care in Advanced Cancers
NCT03607643Phase 2Unknown
- Sponsor
- Diverse Biotech
- Start
- Jan 2019
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in multiple myeloma (MM), glioblastoma multiforme (GBM), pancreatic cancer (PC), colon cancer, rectal cancer, sponsored by Diverse Biotech. Status: unknown.
02
Drugs
cannabidiol
03
Conditions
multiple myeloma (MM)glioblastoma multiforme (GBM)pancreatic cancer (PC)colon cancerrectal cancer
Beyond the preview
Go deeper on NCT03607643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03607643.